Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Klinic vs Recovery Delivered

Klinic
Graded #313

Higher grade

vs+0.09999999999999432
Recovery Delivered
Graded #318

Lower grade

The verdict

Klinic takes it — 60.8/100 to 60.7/100, but only just.

Klinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Klinic is a LegitScript-certified multi-condition telehealth platform prescribing brand-name GLP-1 medications—Wegovy (semaglutide) and Zepbound (tirzepatide)—to patients across all 50 U.S. Recovery Delivered is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRecovery Delivered +1
45
46
Dose & formulationRecovery Delivered +12
53
65
Clinical oversightKlinic +4
79
75
Labs & monitoringKlinic +12
64
52
FulfillmentKlinic +1
76
75
Contract termsEven
55
55
Klinic · left barRecovery Delivered · right bar

The numbers

MetricKlinicRecovery Delivered
WeighScore60.8/10060.7/100
GradeCC
Scorecard rank#313#318
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$219/mo (2.5 mg dose, compounded)
CoverageCoverage not published32 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Klinic

Graded #313 · C

Strengths

  • LegitScript certified, licensed in all 50 states, DEA registered, HIPAA/SOC 2 Type II compliant
  • Broad insurance acceptance including Medicare, Medicaid, BCBS, Aetna, Cigna, UHC, and Humana
  • Klinic handles all prior authorization—patient never manages PA paperwork
  • Brand-name FDA-approved GLP-1s (Wegovy, Zepbound) at full clinical doses with home delivery
  • Named clinical leadership (CMO Dr. Saba Haq, Chief Physician Dr. Vivek Chander) and disclosed founder

Where it loses points

  • Brand-name meds are costly self-pay: Wegovy ~$499/month, Zepbound ~$299/month (med cost alone; consult extra)
  • No compounded semaglutide or tirzepatide option for patients seeking lower-cost alternatives
  • Medication cost is separate from visit fees ($99 initial, $75 follow-up) — total self-pay cost is higher
  • No labs or dedicated nutrition/coaching program included in any plan
  • Pharmacy fulfillment via Klinic Pharmacy Hub Services LLC (non-dispensing hub); actual dispensing is third-party
Recovery Delivered

Graded #318 · C

Strengths

  • Low entry price: compounded semaglutide from $199.99/mo, tirzepatide from $219/mo
  • Video visit with a provider and home delivery included in the price
  • Offers both injectable and oral compounded GLP-1 options

Where it loses points

  • Compounding pharmacy is not publicly named
  • Not available in 19 states (including CA, IL, TN, GA, MI)
  • Higher semaglutide doses cost up to $299.99/mo

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard